{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:02:04Z","timestamp":1793271724746,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["COVID190114"],"award-info":[{"award-number":["COVID190114"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["23220712"],"award-info":[{"award-number":["23220712"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["CID-HKU1-9"],"award-info":[{"award-number":["CID-HKU1-9"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC0866100"],"award-info":[{"award-number":["2021YFC0866100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3041600"],"award-info":[{"award-number":["2023YFC3041600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFE0203400"],"award-info":[{"award-number":["2023YFE0203400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007156","name":"Innovation and Technology Commission - Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ebiom.2025.105662","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T04:01:08Z","timestamp":1742875268000},"page":"105662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A live attenuated SARS-CoV-2 vaccine constructed by dual inactivation of NSP16 and ORF3a"],"prefix":"10.1016","volume":"114","author":[{"given":"Zi-Wei","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6137-7926","authenticated-orcid":false,"given":"Chon Phin","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8974-2265","authenticated-orcid":false,"given":"Hehe","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7310-6744","authenticated-orcid":false,"given":"Kaiming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Sebastien","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pak-Hin","family":"Hinson Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Ping","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7688-6181","authenticated-orcid":false,"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang Sheng","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuofeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2778-3530","authenticated-orcid":false,"given":"Dong-Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105662_bib1","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1126\/science.abn4543","article-title":"Track Omicron's spread with molecular data","volume":"374","author":"Scott","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2025.105662_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41392-022-01105-9","article-title":"Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages","volume":"7","author":"Xia","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ebiom.2025.105662_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105662_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","article-title":"Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron","volume":"603","author":"Shuai","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105662_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.abn8939","article-title":"Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters","volume":"377","author":"Yuan","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2025.105662_bib6","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"COVID-19 vaccine effectiveness against the Omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105662_bib7","article-title":"Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong","volume":"32","author":"Zhou","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.ebiom.2025.105662_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104446","article-title":"Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study","volume":"88","author":"Fong","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2025.105662_bib9","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1038\/s41467-022-30884-6","article-title":"Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine","volume":"13","author":"Patalon","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105662_bib10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41467-023-36566-1","article-title":"Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes","volume":"14","author":"Grewal","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105662_bib11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after COVID-19 vaccination and previous infection","volume":"386","author":"Hall","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105662_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1473-3099(23)00060-9","article-title":"Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study","volume":"23","author":"Tan","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105662_bib13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2025.105662_bib14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105662_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2023.101347","article-title":"Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine","volume":"62","author":"Yeung","year":"2023","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.ebiom.2025.105662_bib16","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/s41467-022-32389-8","article-title":"SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals","volume":"13","author":"Sano","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105662_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination","volume":"7","author":"Tang","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ebiom.2025.105662_bib18","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","article-title":"Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization","volume":"12","author":"Lapuente","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105662_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A\u00a0single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105662_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"van Doremalen","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2025.105662_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41392-023-01423-6","article-title":"Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ebiom.2025.105662_bib22","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/s41467-023-37697-1","article-title":"An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters","volume":"14","author":"Deng","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105662_bib23","article-title":"A\u00a0highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike","volume":"119","author":"Zhang","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.105662_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202069119","article-title":"Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection","volume":"119","author":"Americo","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.105662_bib25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-023-06809-8","article-title":"Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization","volume":"624","author":"Ye","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105662_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41579-021-00542-7","article-title":"Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract","volume":"19","author":"Flerlage","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2025.105662_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2024.2316438","article-title":"Pathogenesis and virulence of coronavirus disease: comparative pathology of animal models for COVID-19","volume":"15","author":"Kirk","year":"2024","journal-title":"Virulence"},{"key":"10.1016\/j.ebiom.2025.105662_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2014.06.013","article-title":"Accessory proteins of SARS-CoV and other coronaviruses","volume":"109","author":"Liu","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ebiom.2025.105662_bib29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41586-021-04245-0","article-title":"The N501Y spike substitution enhances SARS-CoV-2 infection and transmission","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105662_bib30","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1080\/22221751.2022.2111977","article-title":"The spike receptor-binding motif G496S substitution determines the replication fitness of SARS-CoV-2 Omicron sublineage","volume":"11","author":"Liang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ebiom.2025.105662_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28326","article-title":"Comparative analysis of SARS-CoV-2 Omicron BA.2.12.1 and BA.5.2 variants","volume":"95","author":"Ong","year":"2023","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.ebiom.2025.105662_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2023.12.026","article-title":"Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants","volume":"187","author":"Qu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105662_bib33","first-page":"793","article-title":"The mechanism of RNA capping by SARS-CoV-2","volume":"609","author":"Park","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105662_bib34","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/v13040538","article-title":"NSP16 2'-O-MTase in coronavirus pathogenesis: possible prevention and treatments strategies","volume":"13","author":"Chang","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2025.105662_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01532-22","article-title":"SARS-CoV-2 uses Nonstructural Protein 16 to evade restriction by IFIT1 and IFIT3","volume":"97","author":"Schindewolf","year":"2023","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2025.105662_bib36","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202255648","article-title":"Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restriction","volume":"23","author":"Russ","year":"2022","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ebiom.2025.105662_bib37","doi-asserted-by":"crossref","first-page":"8865","DOI":"10.1096\/fj.201802418R","article-title":"Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC","volume":"33","author":"Siu","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.ebiom.2025.105662_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2022.01.003","article-title":"SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway","volume":"568","author":"Xu","year":"2022","journal-title":"Virology"},{"key":"10.1016\/j.ebiom.2025.105662_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41420-024-01966-9","article-title":"SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1\u03b1 in pulmonary epithelial and endothelial cells","volume":"10","author":"Ambro\u017cek-Latecka","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.ebiom.2025.105662_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03030-23","article-title":"Endoplasmic reticulum-associated SARS-CoV-2 ORF3a elicits heightened cytopathic effects despite robust ER-associated degradation","volume":"15","author":"Zhang","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2025.105662_bib41","article-title":"Understanding the role of SARS-CoV-2 ORF3a in viral pathogenesis and COVID-19","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ebiom.2025.105662_bib42","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84477","article-title":"The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins","volume":"12","author":"Miller","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.ebiom.2025.105662_bib43","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208525120","article-title":"SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression","volume":"120","author":"Arshad","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.105662_bib44","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1016\/j.devcel.2021.10.006","article-title":"ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress","volume":"56","author":"Chen","year":"2021","journal-title":"Dev Cell"},{"key":"10.1016\/j.ebiom.2025.105662_bib45","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202357224","article-title":"Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release","volume":"24","author":"Stewart","year":"2023","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ebiom.2025.105662_bib46","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1038\/s41467-024-46417-2","article-title":"SARS-CoV-2 virulence factor ORF3a blocks lysosome function by modulating TBC1D5-dependent Rab7 GTPase cycle","volume":"15","author":"Walia","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105662_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199086","article-title":"SARS-CoV-2 ORF3a positively regulates NF-\u03baB activity by enhancing IKK\u03b2-NEMO interaction","volume":"328","author":"Nie","year":"2023","journal-title":"Virus Res"},{"key":"10.1016\/j.ebiom.2025.105662_bib48","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3390\/v15112229","article-title":"SARS-CoV-2 ORF3a-mediated NF-\u03baB activation is not dependent on TRAF-binding sequence","volume":"15","author":"Busscher","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2025.105662_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28175","article-title":"SARS-CoV-2 ORF3a inhibits cGAS-STING-mediated autophagy flux and antiviral function","volume":"95","author":"Su","year":"2023","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.ebiom.2025.105662_bib50","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1080\/15548627.2022.2039992","article-title":"SARS-CoV-2 ORF3a induces RETREG1\/FAM134B-dependent reticulophagy and triggers sequential ER stress and inflammatory responses during SARS-CoV-2 infection","volume":"18","author":"Zhang","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.ebiom.2025.105662_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28959","article-title":"Regulation of autophagy by SARS-CoV-2: the multifunctional contributions of ORF3a","volume":"95","author":"Shariq","year":"2023","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.ebiom.2025.105662_bib52","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41423-020-0485-9","article-title":"The ORF3a protein of SARS-CoV-2 induces apoptosis in cells","volume":"17","author":"Ren","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ebiom.2025.105662_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102752","article-title":"SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis","volume":"63","author":"Liu","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.ebiom.2025.105662_bib54","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nprot.2008.227","article-title":"Recombineering: a homologous recombination-based method of genetic engineering","volume":"4","author":"Sharan","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ebiom.2025.105662_bib55","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41423-022-00855-4","article-title":"Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals","volume":"19","author":"Ye","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ebiom.2025.105662_bib56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41541-023-00776-x","article-title":"Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants","volume":"8","author":"Ong","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2025.105662_bib57","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1002\/jmv.28057","article-title":"Production of single-cycle infectious SARS-CoV-2 through a trans-complemented replicon","volume":"94","author":"Cheung","year":"2022","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.ebiom.2025.105662_bib58","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/gni035","article-title":"Simple and highly efficient BAC recombineering using galK selection","volume":"33","author":"Warming","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2025.105662_bib59","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe cute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2025.105662_bib60","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","article-title":"A\u00a0SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction","volume":"38","author":"Tan","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ebiom.2025.105662_bib61","first-page":"785","article-title":"Coronaviruses exploit a host cysteine-aspartic protease for replication","volume":"609","author":"Chu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105662_bib62","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1016\/j.molcel.2021.04.008","article-title":"Functional landscape of SARS-CoV-2 cellular restriction","volume":"81","author":"Martin-Sancho","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.ebiom.2025.105662_bib63","first-page":"62","article-title":"SARS-CoV-2 variant-dependent inflammasome activation","volume":"87","author":"Teyssou","year":"2023","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ebiom.2025.105662_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010479","article-title":"CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses","volume":"18","author":"Jalloh","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2025.105662_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11929","article-title":"ASC filament formation serves as a signal amplification mechanism for inflammasomes","volume":"7","author":"Dick","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105662_bib66","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ebiom.2025.105662_bib67","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2025.105662_bib68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fimmu.2011.00010","article-title":"The role of TLR2 and bacterial lipoprotein in enhancing airway inflammation and immunity","volume":"2","author":"Lugade","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2025.105662_bib69","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ebiom.2025.105662_bib70","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.immuni.2018.03.015","article-title":"KLRG1+ effector CD8+ T cells lose KLRG1, differentiate into all memory T cell lineages, and convey enhanced protective immunity","volume":"48","author":"Herndler-Brandstetter","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2025.105662_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-021-00657-1","article-title":"The germinal centre B cell response to SARS-CoV-2","volume":"22","author":"Laidlaw","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2025.105662_bib72","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41590-022-01253-8","article-title":"Targeting TFH cells in human diseases and vaccination: rationale and practice","volume":"23","author":"Yu","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2025.105662_bib73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105662_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112443","article-title":"Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants","volume":"42","author":"Qu","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2025.105662_bib75","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: historical successes and current challenges","volume":"479\u2013480","author":"Minor","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.ebiom.2025.105662_bib76","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/mi.2013.67","article-title":"Lung niches for the generation and maintenance of tissue-resident memory T cells","volume":"7","author":"Turner","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ebiom.2025.105662_bib77","article-title":"Nsp3-N interactions are critical for SARS-CoV-2 fitness and virulence","volume":"120","author":"Li","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.105662_bib78","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-020-00241-4","article-title":"Crystal structure of SARS-CoV-2 nsp10\/nsp16 2'-O-methylase and its implication on antiviral drug design","volume":"5","author":"Lin","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ebiom.2025.105662_bib79","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13578-021-00644-y","article-title":"Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication","volume":"11","author":"Jiang","year":"2021","journal-title":"Cell Biosci"},{"key":"10.1016\/j.ebiom.2025.105662_bib80","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00402-21","article-title":"Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 human ACE2 transgenic mice","volume":"95","author":"Silvas","year":"2021","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2025.105662_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.595722","article-title":"Dynamic immune\/inflammation precision medicine: the good and the bad inflammation in infection and cancer","volume":"12","author":"Rossi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2025.105662_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810719","article-title":"Involvement of inflammation and its resolution in disease and therapeutics","volume":"23","author":"Alfaro","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2025.105662_bib83","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/jleuko\/qiad097","article-title":"Chemokine Cxcl1-Cxcl2 heterodimer is a potent neutrophil chemoattractant","volume":"114","author":"Sawant","year":"2023","journal-title":"J\u00a0Leukoc Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105662_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104453","article-title":"Neutrophils recruited to immunization sites initiating vaccine-induced antibody responses by locally expression BAFF","volume":"25","author":"Wang","year":"2022","journal-title":"iScience"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105662_bib85","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/infdis\/jiaa242","article-title":"Neutrophils are required during immunization with the pneumococcal conjugate vaccine for protective antibody responses and host defense against infection","volume":"222","author":"Tchalla","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105662_bib86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/JLB.3MR0620-550R","article-title":"Molecular interactions and functions of IL-32","volume":"109","author":"Aass","year":"2021","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.ebiom.2025.105662_bib87","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14760584.2021.1927724","article-title":"Type I and II interferons toward ideal vaccine and immunotherapy","volume":"20","author":"Temizoz","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ebiom.2025.105662_bib88","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1128\/JVI.02161-15","article-title":"PACT- and RIG-I-dependent activation of type I interferon production by a defective interfering RNA derived from measles virus vaccine","volume":"90","author":"Ho","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2025.105662_bib89","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1080\/22221751.2022.2088406","article-title":"Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial","volume":"11","author":"Wang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ebiom.2025.105662_bib90","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1038\/s41467-023-42349-5","article-title":"An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models","volume":"14","author":"Yuen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105662_bib91","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/cid\/ciab684","article-title":"False coronavirus disease 2019 cases due to contamination by inactivated virus vaccine","volume":"74","author":"To","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105662_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009233","article-title":"SARS-CoV-2 variants with mutations at the S1\/S2 cleavage site are generated in\u00a0vitro during propagation in TMPRSS2-deficient cells","volume":"17","author":"Sasaki","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2025.105662_bib93","doi-asserted-by":"crossref","first-page":"12546","DOI":"10.1073\/pnas.0605438103","article-title":"Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering a recombination-resistant genome","volume":"103","author":"Yount","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:16:02Z","timestamp":1762618562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425001069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":93,"alternative-id":["S2352396425001069"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105662","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A live attenuated SARS-CoV-2 vaccine constructed by dual inactivation of NSP16 and ORF3a","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105662"}}